AmniotextTM is less invasive than adipose tissue extraction and bone marrow aspiration resulting in shorter procedure times and most importantly, less pain.
Commonly used corticosteroid injections lead to deterioration of cartilage. AmniotextTM aids the body’s reparative efforts by supporting cell adhesion. Amniotic tissue allografts used at wound or surgical sites have been shown to reduce scarring adhesions, and fibrosis. Additionally, it provides an anti-microbial and anti- inflammatory environment at these sites promoting tissue regeneration.
AmniotextTM is regulated under the Public Health Service Act 21 CFR Part 1271, Section 361. It is derived from donated, full term deliveries in accordance with the FDA. It is a regulated, human cell, tissue, or cellular or tissued based product (HCT/P).